Nicholas K. Terrett
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicholas K. Terrett.
Bioorganic & Medicinal Chemistry Letters | 1996
Nicholas K. Terrett; Andrew Simon Bell; David Brown; Peter M. Ellis
Abstract 5-(2′-Alkoxyphenyl)pyrazolo[4,3-d]pyrimidin-7-ones, and in particular our preferred compound, sildenafil (VIAGRATM), discovered through a rational drug design programme, are potent and selective inhibitors of the type 5 cGMP phosphodiesterase from both rabbit platelets and human corpus cavernosum. Sildenafil is currently in the clinic for the oral treatment of male erectile dysfunction.
Journal of Molecular Graphics & Modelling | 1997
Michael Snarey; Nicholas K. Terrett; Peter Willett; David J. Wilton
Dissimilarity-based compound selection has been suggested as an effective method for selecting structurally diverse subsets of chemical databases. This article reports a comparison of several maximum-dissimilarity and sphere-exclusion algorithms for dissimilarity-based selection. The effectiveness of the algorithms is quantified by the numbers of biological activity classes identified in subsets selected from the World Drugs Index database, and by the numbers of active compounds identified in feedback searches of this database. The experiments demonstrate the general effectiveness and efficiency of the MaxMin algorithm.
Journal of Organometallic Chemistry | 1984
Ian Fleming; Nicholas K. Terrett
Abstract The stereospecifically anti synthesis of allyl- and allenyl-silanes by the reaction of a silylcuprate reagent with allyl and propargyl acetates is described. The S E 2′ reactions of these silanes with various electrophiles are shown to proceed with predominantly anti stereoselectivity, offset to a greater or lesser extent by other steric factors.
Biochemical and Biophysical Research Communications | 1989
John Christopher Danilewicz; P.L. Barclay; Ian T. Barnish; D. Brown; S.F. Campbell; Keith James; Gillian Mary Ryder Samuels; Nicholas K. Terrett; Martin James Wythes
A search for potent inhibitors of EC 3.4.24.11, an enzyme which is found most abundantly in the kidney and which degrades atrial natriuretic factor, has led to the identification of UK-69,578. Structure-activity studies starting from substituted N-carboxymethyl dipeptide inhibitors resulted in the introduction of a cyclo-alkane P1 residue and in the replacement of the aza-link between P1 and P1 residues by a methylene group, with a net ten-fold potency gain. UK-69,578 increases endogenous ANF levels and produces natriuretic and diuretic responses intravenously in mice.
Bioorganic & Medicinal Chemistry | 1996
Christopher N. Selway; Nicholas K. Terrett
Parallel compound synthesis enables large numbers of individual compounds to be prepared simultaneously using semiautomated techniques. This fast and efficient methodology has an important role to play in accelerating lead optimisation and hence the whole drug discovery process. The potential of this strategy to rapidly optimise chemical leads and provide structure-activity relationship (SAR) information was demonstrated in two therapeutic areas, antiviral agents (herpes simplex virus), and neurokinin-2 receptor antagonists.
Journal of Medicinal Chemistry | 2015
Benjamin A. Seigal; William H. Connors; Andrew Fraley; Robert M. Borzilleri; Percy H. Carter; Stuart Emanuel; Joseph Fargnoli; Kyoung S. Kim; Ming Lei; Joseph G. Naglich; Matthew E. Pokross; Shana Posy; Henry Shen; Neha Surti; Randy Talbott; Yong Zhang; Nicholas K. Terrett
Affinity selection screening of macrocycle libraries derived from DNA-programmed chemistry identified XIAP BIR2 and BIR3 domain inhibitors that displace bound pro-apoptotic caspases. X-ray cocrystal structures of key compounds with XIAP BIR2 suggested potency-enhancing structural modifications. Optimization of dimeric macrocycles with similar affinity for both domains were potent pro-apoptotic agents in cancer cell lines and efficacious in shrinking tumors in a mouse xenograft model.
Tetrahedron | 1995
W. Russell Bowman; Peter T. Stephenson; Nicholas K. Terrett; Adrian R. Young
Abstract Radical cyclisation of sp 3 carbon-centred radicals onto imines and hydrazones provides a new method for the synthesis of 5- and 6-membered ring nitrogen heterocycles. Cyclisation onto the electrophilic carbon of the C=N group and 5- exo stereoelectronic selectivity are the dominating mechanistic parameters. The C-centred radical intermediates were generated from benzeneselenyl precursors using Bu 3 SnH.
Tetrahedron | 1990
Donald S. Middleton; Nigel S. Simpkins; Michael J. Begley; Nicholas K. Terrett
Abstract A variety of spiroether products, including one bis-spiro compound, are available via a simple radical cyclisation route.
Tetrahedron Letters | 1983
Ian Fleming; Nicholas K. Terrett
Abstract The SE2′ reactions of 1 and 2 with a range of electrophiles are predominantly anti in the allylsilane portion of the molecule, but this is offset, to a greater or lesser extent, by axial or equatorial preferences in the ring system.
Bioorganic & Medicinal Chemistry Letters | 1995
Nicholas K. Terrett; Dejan Bojanic; David Brown; Peter J. Bungay; Mark Gardner; David W. Gordon; Carolyn J. Mayers; John Steele
Abstract A combinatorial library of 30,752 compounds has been synthesised from a set of 32 natural and unnatural amino acids. The library was designed to include the known endothelin antagonist, FR-139,317, as a positive control, and this and a number of close analogues were shown to be the most potent compounds. Thus, combinatorial libraries may be used both to discover leads and rapidly explore SAR. A combinatorial library of 30,752 compounds has been synthesised from a set of 32 natural and unnatural amino acids. The library was designed to include the known endothelin antagonist, FR-139,317, as a positive control, and this and a number of close analogues were shown to be the most potent compounds. Thus, combinatorial libraries may be used both to discover leads and rapidly explore SAR.